As per the information provided by the Uzbekistan's presidential press service, Shavkat Mirziyoyev got acquainted with the presentation of proposals to accelerate reforms in the healthcare sector on January 22.
The Uzbekistan 2030 strategy serves as the guiding framework, outlining crucial tasks aimed at safeguarding public health and elevating the quality of medical services. To propel these reforms forward with efficiency, a set of proposals has been crafted, drawing insights from international experts.
One key proposal is the establishment of a groundbreaking initiative—the "Center for Healthcare Projects."
To ensure the success of these endeavors, the project office will tap into the expertise of experienced specialists from specialized medical centers, higher education and research institutions, as well as engage foreign experts and consultants on a contractual basis.
Recognizing that impactful reforms hinge on a well-equipped workforce, the proposals outline measures to strengthen human resources in the healthcare sector. Notably, the Tashkent Medical Academy is set to undergo international accreditation for its educational programs. Master's programs in public health, preventive medicine, and physical activity will be introduced.
Specialized medical centers, including those focused on surgery, cardiology, endocrinology, dermatovenereology, and cosmetology, along with the Children's National Medical Center and the National Medical Center, are poised to undergo international accreditation—an initiative aimed at ensuring that these centers meet global standards of excellence.
In a commitment to alignment with international benchmarks, the coming year will see the revision of 40 existing sanitary rules and regulations, aligning them with global standards.
President Mirziyoyev, endorsing these proposals, has ordered the formulation of a comprehensive "road map" to guide the seamless implementation of these healthcare priorities.
Earlier Daryo reported that the Tax Committee of Uzbekistan has declared the discontinuation of Value Added Tax (VAT) exemptions for medicines and medical services, starting from April 1, 2024, as part of adjustments to the tax and budget policies for the forthcoming year. The revised regulations imply the removal of VAT benefits on the circulation and import of pharmaceutical items. Consequently, VAT will be levied on the transactions involving medical services, veterinary services, medications, as well as veterinary drugs, and medical and veterinary products.
Comments (0)